• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.29% Nasdaq Down 3.25%

    More On 009420.KS

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    HanAll Biopharma Co., Ltd. (009420.KS)

    -KSE
    12,850.00 Down 100.00(0.77%) Feb 5, 1:00AM EST
    Prev Close:12,950.00
    Open:13,050.00
    Bid:12,850.00
    Ask:12,900.00
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:12,800.00 - 13,150.00
    52wk Range:4,195.00 - 18,150.00
    Volume:168,637
    Avg Vol (3m):496,212
    Market Cap:641.75B
    P/E (ttm):N/A
    EPS (ttm):-384.82
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in KRW.

    Headlines

    • No Headlines available for 009420.KS at this time.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):7.61
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    HanAll BioPharma Co., Ltd. engages in the research and development of biopharmaceutical products worldwide. Its products under development include HL161, an anti-hFcRn mAb for the treatment of pemphigus, NMO, MG, and lupus nephritis, as well as to... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback